Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Annals of Hematology|May 1, 2017
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trialLukas Weiss, Thomas Melchardt, Alexander Egle, et al.
Oncology Letters|November 22, 2013
Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndromeThomas Melchardt, Lukas Weiss, Lisa Pleyer, et al.
Annals of Hematology|January 21, 2014
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trialGeorg Hopfinger, Thomas Nösslinger, Alois Lang, et al.
Plos One|November 10, 2018
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parametersKonstantin Schlick, Teresa Magnes, Lukas Ratzinger, et al.
Clinical Colorectal Cancer|May 8, 2019
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal CancerFlorian Huemer, Verena Schlintl, Stefan Hecht, et al.
International Journal of Molecular Sciences|June 2, 2021
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell TherapyDominik Kiem, Michael Leisch, Daniel Neureiter, et al.
European Journal of Haematology|June 29, 2025
Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid RegistryDominik Kiem, Michael Leisch, Ildiko Toth, et al.
Wiener Klinische Wochenschrift|November 24, 2016
Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case reportFlorian Huemer, Martin Dejaco, Christoph Grabmer, et al.
BMC Complementary and Alternative Medicine|April 1, 2014
Liver toxicity during temozolomide chemotherapy caused by Chinese herbsThomas Melchardt, Teresa Magnes, Lukas Weiss, et al.
Journal of Clinical Medicine|November 14, 2019
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer PatientsKonstantin Schlick, Teresa Magnes, Florian Huemer, et al.
Pageof 9